Intervention Review

You have free access to this content

Aripiprazole versus other atypical antipsychotics for schizophrenia

  1. Priya Khanna1,
  2. Tao Suo2,*,
  3. Katja Komossa3,
  4. Huaixing Ma4,
  5. Christine Rummel-Kluge5,
  6. Hany George El-Sayeh6,
  7. Stefan Leucht7,
  8. Jun Xia8

Editorial Group: Cochrane Schizophrenia Group

Published Online: 2 JAN 2014

Assessed as up-to-date: 24 JUN 2013

DOI: 10.1002/14651858.CD006569.pub5


How to Cite

Khanna P, Suo T, Komossa K, Ma H, Rummel-Kluge C, El-Sayeh HG, Leucht S, Xia J. Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD006569. DOI: 10.1002/14651858.CD006569.pub5.

Author Information

  1. 1

    Northumberland, Tyne and Wear NHS Foundation Trust, Early Intervention Psychosis, Newcastle, UK

  2. 2

    Zhongshan Hospital, Fudan University, Department of General Surgery, Institute of General Surgery, Shanghai, Shanghai, China

  3. 3

    University Hospital of Zurich, Department of Psychiatry and Psychotherapy, Zurich, Switzerland

  4. 4

    Zhongshan Hospital, Fudan University, Department of Medical Oncology, Shanghai, China

  5. 5

    University of Leipzig, Clinic and Outpatient Clinic of Psychiatry and Psychotherapy, Leipzig, Saxony, Germany

  6. 6

    Harrogate District Hospital, Briary Wing, Harrogate, West Yorkshire, UK

  7. 7

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  8. 8

    Systematic Review Solutions Ltd, Yan Tai, China

*Tao Suo, Department of General Surgery, Institute of General Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai, Shanghai, 200032, China. simonsuo@aliyun.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 2 JAN 2014

SEARCH

  1. You have free access to this content

    Current Version

    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel-Kluge, Hany George El-Sayeh, Stefan Leucht and Jun Xia

    Article first published online: 2 JAN 2014 | DOI: 10.1002/14651858.CD006569.pub5

Previous versions of this article and their online publication dates

  1. You have free access to this content

    Version 4

    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Priya Khanna, Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Sandra Schwarz, Hany George El-Sayeh and Stefan Leucht

    Article first published online: 28 FEB 2013 | DOI: 10.1002/14651858.CD006569.pub4

  2. Version 3

    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Katja Komossa, Christine Rummel-Kluge, Franziska Schmid, Heike Hunger, Sandra Schwarz, Hany George G El-Sayeh, Werner Kissling and Stefan Leucht

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD006569.pub3

  3. Version 2

    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Katja Komossa, Christine Rummel-Kluge, Franziska Schmidt, Heike Hunger, Sandra Schwarz, Hany George G El-Sayeh, Werner Kissling and Stefan Leucht

    Article first published online: 18 JUL 2007 | DOI: 10.1002/14651858.CD006569.pub2

  4. Version 1

    Aripiprazole versus other atypical antipsychotics for schizophrenia

    K Komossa, H Hunger, C Rummel, HG El-Sayeh and S Leucht

    Article first published online: 18 APR 2007 | DOI: 10.1002/14651858.CD006569